
Keywords: عامل نکروز تومور; TNF, tumor necrosis factor alpha; CD, Crohn's disease; HBI, Harvey–Bradshaw index; 95% CI, 95% confidence intervalCrohn's disease; De-intensification; Loss of response; Tumour necrosis factor; Infliximab; AdalimumabEnfermedad de Crohn; Desintensificación;